Skip to main content
. 2017 Dec 1;3(3):555–572. doi: 10.1016/j.ekir.2017.11.019

Table 3.

Selected miRNAs showing differential concentration between non-MA and MA intermittent patients

Starting fraction miRNA IM:NO-AVE (log2CPM) IM:MA-AVE (log2CPM) Log2FC P
Urine hsa-miR-3168-5p 10.23 7.24 -2.99 0.0153
hsa-miR-342-3p 9.06 10.27 1.21 0.0487
hsa-miR-152-3p 8.28 9.41 1.13 0.0164
hsa-miR-339-3p 6.87 8.00 1.13 0.0392
hsa-miR-4286-5p 9.58 8.47 -1.11 0.0270
hsa-miR-192-5p 10.17 9.13 -1.03 0.0320
hsa-miR-362-5p 8.43 7.42 -1.01 0.0458
hsa-miR-197-3p 9.53 8.56 -0.97 0.0296
hsa-miR-1307-3p 9.67 8.78 -0.88 0.0159
hsa-miR-188-5p 6.82 5.23 -1.58 0.0128
hsa-miR-424-3p 7.16 5.25 -1.91 0.0192
EV hsa-miR-671-5p 6.43 3.32 -3.12 0.0451

AVE, average; CPM, counts per million; EV, extracellular vesicle; FC, fold change; MA, microalbuminuria; miRNA, microRNA; IMA:NO, Intermittent MA: non-MA cycle; IMA:MA, Intermittent MA:MA cycle.

See Supplementary Table S3 for additional details.